消癣康肤制剂治疗寻常型银屑病的临床研究

Clinical Study on Xiaoxuan Kangfu Capsule in the Treatment of Psoriasis Vulgaris

目的观察消癣康肤制剂治疗寻常型银屑病的临床疗效。方法将患者随机分为治疗组和对照组，对照组口服复方青黛胶囊，4粒，次，3次，d；治疗组患者应用消癣康肤制剂6粒／次，早晚两次服用，两组均30d为1个疗程，根据病情治疗1～3个疗程，比较两组患者治愈、好转率及治疗时间。结果治疗组痊愈34例（42．5％），总有效率87．5％；对照组痊愈14例（17．5％），总有效率72．5％（P〈0.05）。治疗组治愈时间短于对照组（P〈0.05）。结论消癣康肤制剂治疗寻常型银屑病治愈率高，痊愈时间短，复发率低，值得临床推广。

Objective To investigate the therapeutic effect of Xiaoxuan Kangfu capsule in treating psoriasis vulgaris. Methods All patients were divided into two groups randomly （60 patients in a control group and 60 patients in a treatment group）. In the control group complex Qingdai capsule was given to the patients, with 4 pills for each time and 3 times daily. While in treatment group Xiaoxuan Kangfu capsule was given to the patients with 6 pills for each time and twice daily. 30 days consisted one treatment period for both groups. The patients undertook one to three treatment period according to the patients＇ pathogenetic condition. The rates of recovery and improvement and were compared. Results In the treatment group, 34 patients were cured （42.5%）, and the total effective rate was 87.5%; while in the control group 14 patients were cured （7.5%）, and the total effective rate was 72.5%. There was statistic difference between the two groups （P〈0.05）. The average heal time of the treatment group was shorter than that of the control group, showing statistic difference （P〈0.05）. Conclusion Xiaoxuan Kangfu capsule showed higher recovery rate, shorter healing time and lower recurrence rate in treating psoriasis vulgaris than complex Qingdai capsule. The treatment is deserving clinical spread.